| 标题 |
Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non-small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical lung cancer 作者:Miura S; Yamanaka T; Kato T; Ikeda S; Horinouchi H; et al 出版日期:2020/11/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)